Anymedi Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Revenue	334.34	131.75	83.51
Other Revenue	-	-	-0
Revenue	334.34	131.75	83.51
Revenue Growth (YoY)	153.78%	57.77%	-
Cost of Revenue	650.05	248.69	588.53
Gross Profit	-315.71	-116.94	-505.03
Selling, General & Admin	3,733	1,600	993.45
Research & Development	3,044	1,602	724.15
Other Operating Expenses	47.46	30.12	14.68
Operating Expenses	7,555	3,623	1,807
Operating Income	-7,871	-3,739	-2,312
Interest Expense	-359.69	-330.1	-6.7
Interest & Investment Income	25.99	9.16	3.01
Other Non Operating Income (Expenses)	-2,953	-481.57	33.61
EBT Excluding Unusual Items	-11,158	-4,542	-2,282
Gain (Loss) on Sale of Assets	-0.13	-13.47	-
Pretax Income	-11,158	-4,555	-2,282
Net Income	-11,158	-4,555	-2,282
Net Income to Common	-11,158	-4,555	-2,282
Shares Outstanding (Basic)	6	5	0
Shares Outstanding (Diluted)	6	5	0
Shares Change (YoY)	16.83%	4900.13%	-
EPS (Basic)	-1998.00	-953.00	-23875.20
EPS (Diluted)	-1998.00	-953.00	-23875.20
Free Cash Flow	-7,543	-7,378	-2,188
Free Cash Flow Per Share	-1350.75	-1543.42	-22887.10
Gross Margin	-94.43%	-88.76%	-
Operating Margin	-2354.10%	-2838.39%	-2769.08%
Profit Margin	-3337.30%	-3457.75%	-2733.25%
Free Cash Flow Margin	-2256.19%	-5599.97%	-2620.13%
EBITDA	-6,888	-3,165	-2,094
D&A For EBITDA	982.42	574.85	218
EBIT	-7,871	-3,739	-2,312
Advertising Expenses	999.74	262.27	202.89

Source: S&P Global Market Intelligence. Standard template. Financial Sources.